Half a decade after receiving a psychedelic treatment for depression, two-thirds of patients in a new study remained in ...

A groundbreaking study reveals that a single dose of psilocybin, the active compound in magic mushrooms, can provide ...

New research shows a single psilocybin session with therapy can reduce depression in cancer patients for up to two years.

In a phase 2 trial, about half of cancer patients reported sustained reductions in depression and anxiety 2 years after a ...

Scientists have dug up more evidence of the benefits of so-called "magic" mushrooms with the publication of clinical trial ...

Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in ...

The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...

New Zealand has approved the restricted medicinal use of psilocybin, a hallucinogen found in “magic mushrooms” for patients ...

A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...

New research shows psilocybin can produce lasting reductions in depression and anxiety in cancer patients with major ...

New research shows a single dose leads to 'robust' reductions in depression and anxiety up to 2 years afterward.

A pilot study involving psilocybin-assisted therapy found possible antidepressant effects for people with bipolar II disorder ...